My first job out of college was as a medical device analyst. Later I’d work in pharma before going back to finance. When I was diagnosed with breast cancer, I thought I knew something about healthcare.

I started my treatment at the best-ranked center with the best reported outcomes, and if I’d stayed there, if I’d listened to my doctors, if I followed the rules, I’m pretty sure I’d be dead.

Why yes, my dog does accompany me to receive experimental medical therapy.

Cancer is complex, and so is the industry around it. There is kindness in this business. There is innovation. There are passionate people who care about patients and advancing care. And there’s also bias, corruption, power struggles, bad drugs and bad advice, all under the cloud of litigation risk, administrative pressures and departmental politics.

This blog is a mix of my experiences as a patient and my perspective on new drugs and treatments. It’s personal; I have a stake in how and where the money goes, which, as I lilypad from drug to drug, determines how and when I die. And I can’t help it. I just really love talking about shitty drug companies, and I’m happy to celebrate the good ones.

Strategizing my way through metastatic cancer brings me a lot of joy. It’s my life’s work. I want to share it.